English|China's First Oral Drug for COVID-19 Approved English

文章图片

Image Source: Visual China
BEIJING, July 16 (TMTPOST) – Genuine Biotech has received emergency conditional approval for its Azvudine tablets from China’s National Medical products Association (NMPA) for the treatment of adult patients suffering moderate Covid-19.
For a seven-day treatment of Azvudine, which is also used for treating HIV, the total charge is 910 yuan (about US$134). Paxlovid, the only rival of Azvudine in the Chinese market, would cost a patient 2,300 yuan (about US$340).
Shortly after the approval of the drug, Fosun Pharmaceutical, owned by Chinese billionaire Guo Guangchang, announced that it had reached an exclusive strategic partnership with Genuine Biotech on developing and commercializing Azvudine tablets.
Developed initially as a treatment for HIV, Genuine Biotech’s Azvudine tablets also obtained conditional approvals from the NMPA on July 20, 2021 for use in the treatment of HIV in adults in July last year.
Azvudine reported that 40% of people that took the Azvudine improved their COVID symptoms within seven days of taking the drug while, in the control group of unmedicated patients, just 10% of COVID symptoms improved, according to the Genuine Biotech's report.
“Covid-19 continues to mutate, causing pandemic resurgence across the globe. Vaccines and drug treatments remain to be powerful weapons for humans to combat viruses,” Fosun Pharmaceutical’s CEO Wen Deyong said. “Azvudine tablet is the first Covid-19 drug taken by mouth developed by a Chinese company with the approval from the authorities. We believe the recent development will help control and curb the pandemic. We are happy to reach a strategic partnership with Genuine Biotech and hope to develop treatments and prevention solutions for Covid-19.”
【English|China's First Oral Drug for COVID-19 Approved】“We will make use of Fosun Pharmaceutical’s innovation and commercialization capabilities accumulated over years and utilize the advantages from out international operation to bring Azvudine tablets to patients around the world,” Wen said.

English|China's First Oral Drug for COVID-19 Approved

推荐阅读

佳能750d可以换什么样的镜头

面料涤纶里料棉纶的衣服怎么洗面料涤纶里料棉纶的衣服如何洗

快赔和保险有什么区别

mole|预算不超过2000元，要有5g、不卡，朋友们能否给点建议？

崇德老人八字例解（六）

痛风后果严重吗

stm32逻辑分析porta

秋葵焯水要切开不

万能看图王怎么卸载？万能看图王卸载方法

含有近义词的词语含有近义词的词语四字

利用手机QQ无限刷手机上网流量三网通用

新冠疫苗接种后的注意事项打新冠疫苗可以吃生鱼片吗

戒烟的过程中有点心慌是什么情况，要怎么办啊？

得了艾滋病应该怎么办如果患上艾滋病怎么办

夏天如何培养天竺葵盆栽夏天如何培养天竺葵，夏天如何培养天竺葵苗

wi-fi|联想发布 Yoga 7i 翻转本：可选 14/16 英寸屏

分享一下你们最喜欢的微信头像？

《雪鹰领主》进入薪火宫的条件雪鹰领主招募

虚拟主机如何搭建shopex，虚拟主机如何搭建传奇游戏

考研申请书